U.S. Study: 'Risk Creep' For TAVR Began Before FDA Approval (CME/CE)

(MedPage Today) -- Mitral repair also on slow climb, per TVT Registry
via U.S. Study: 'Risk Creep' For TAVR Began Before FDA Approval (CME/CE)
by